This deepening crisis means that without interventions aimed at significantly ramping up affordable housing supply, the city's affordability gap could linger for generations.
Construction is scheduled to begin in the first quarter of 2026 with production operations anticipated to start in January 2027.
The redevelopment will complement the City of Beacon’s efforts to foster greater connectivity between the waterfront, Beacon Station and Main Street.
Construction is scheduled to begin in the first quarter of 2026 with production operations anticipated to start in January 2027.
NEW WINDSOR, NY— Garonit Pharmaceutical, Inc., a global manufacturer of antiseptic products and health care solutions headquartered in Fairfield, NJ, will build a new state-of-the-art, 200,000-sf pharmaceutical manufacturing facility in Orange County.
The $46.1-million project to be built on a vacant parcel adjacent to New York Stewart International Airport in New Windsor will become the world’s largest chlorhexidine gluconate manufacturing operation, producing antiseptic products essential for surgical disinfection and infection prevention in hospitals worldwide, New York State officials said. New York State, which announced the deal on Aug. 4, is supporting the project with $3.8 million, including up to $3.5 million through the Excelsior Jobs Program and a $300,000 Mid-Hudson Regional Economic Development Council capital grant.
The new facility will manufacture antiseptic products, including both ANDA and NDA formulations that are subject to full U.S. Food and Drug Administration approval. The products to be manufactured at this site are commonly used in hospital settings, particularly in surgical environments, with the initial product portfolio focusing on antiseptics designed to maintain sterility and support cleanliness during a wide range of medical procedures. The facility will feature advanced production lines for liquid finished dosage forms and a state-of-the-art laboratory equipped with advanced analytical equipment for quality testing and research. The facility will also house a fully equipped research and development center dedicated to the development of both Active Pharmaceutical Ingredients and Finished Dosage Forms, with a focus on bringing innovative new drugs to the U.S. market.
Construction is scheduled to begin in the first quarter of 2026 with production operations anticipated to start in January 2027. The project will create an estimated 100 to 150 construction jobs during the build phase, and the 100 full-time pharmaceutical positions will include production, quality assurance, warehouse, R&D, administration and logistics, management, and sales roles. The facility will export products to existing customers across North America, Europe, Japan, Australia, and other global markets.
The Orange County Partnership of Goshen worked directly with Garonit executives over the past year on site selection efforts, working with Empire State Development, Gov. Kathy Hochul, and local partners including Orange County Executive Steven Neuhaus and Town of New Windsor Supervisor Stephen Bedetti and others to secure the project. In addition, Garonit Pharmaceutical has begun collaborating with SUNY Orange Community College to develop specialized training programs that will prepare local residents for these high-skill positions.
Rand Commercial announced that the firm’s Paul Adler, Esq., SIOR represented the seller in the transaction for the two parcels totaling 15.50 acres on Bruenig Road in New Windsor. Robert Scherreik of Pyramid Brokerage of the Hudson Valley, LLC. Represented the buyer in the deal.
Garonit Pharmaceutical Inc. Owner Nitin Garg said, “In designing our new manufacturing facility, we were thrilled to incorporate a dedicated technology research and development center in New Windsor, which will serve as a hub for formulating new FDA-regulated products. This milestone is strengthened by our collaboration with SUNY Orange, as we work together to develop programs that bridge operational excellence with advanced research and development.”
Orange County Partnership President & CEO Conor Eckert said, “Garonit USA’s decision to establish its advanced pharmaceutical manufacturing and R&D facility in Orange County represents a major milestone for our region and a step forward in our strategic economic development efforts. This investment will create high-quality careers, strengthen our life sciences and manufacturing ecosystem, and position Orange County as a rising force in next-generation pharmaceutical innovation. We’re grateful to the Garonit team for selecting Orange County—and to Governor Hochul for her direct support in securing this game-changing investment.”
Orange County Executive Steven Neuhaus said, “We are thrilled that Garonit USA has chosen Orange County as the home for its state-of-the-art pharmaceutical manufacturing and R&D facility. This investment underscores the strength of our business climate and our commitment to innovation. The project will create high-quality careers for local residents, fuel long-term growth, and position Orange County for sustainable economic success. We’re proud to support Garonit’s vision and excited to be part of their future.”
Town of New Windsor Supervisor Stephen Bedetti said, “The Town of New Windsor is proud to welcome Garonit USA to our community. Their new state-of-the-art advanced manufacturing facility represents a significant investment in our town, bringing high-quality, well-paying careers to local residents. This project also revitalizes long-vacant land near Stewart Airport, turning it into a hub of innovation and economic growth.”
This deepening crisis means that without interventions aimed at significantly ramping up affordable housing supply, the city's affordability gap could linger for generations.
The redevelopment will complement the City of Beacon’s efforts to foster greater connectivity between the waterfront, Beacon Station and Main Street.
The mayor’s veto puts the $4-billion project to be built at Bally’s Golf Links at Ferry Point in the Bronx back in the running among six other applicants for up to three downstate gaming licenses.
The average contract interest rate for 30-year fixed-rate mortgages with conforming loan balances ($806,500 or less) decreased to 6.83% from 6.84%.
Receive original business news about real estate and the REALTORS® who serve the lower Hudson Valley, delivered straight to your inbox. No credit card required.
